Distinct Early Serological Signatures Track with SARS-CoV-2 Survival
Caroline Atyeo(Ragon Institute of MGH, MIT and Harvard), Galit Alter(Ragon Institute of MGH, MIT and Harvard), Kira L. Newman(University of Michigan), Timothy M. Caradonna(Ragon Institute of MGH, MIT and Harvard), Jingyou Yu(First Affiliated Hospital of Guangzhou Medical University), Richelle C. Charles(Massachusetts General Hospital), Aaron G. Schmidt(Icahn School of Medicine at Mount Sinai), Jared Feldman(Ragon Institute of MGH, MIT and Harvard), Edward T. Ryan(Harvard University), Blake M. Hauser(Ragon Institute of MGH, MIT and Harvard), Carolin Loos(International Council on Mining and Metals), Denise J. McCulloch(University of Washington), Dan H. Barouch(Beth Israel Deaconess Medical Center), Caitlyn Linde, Douglas A. Lauffenburger(Harvard University), Stephanie Fischinger(Leiden University), John S. Burke(Ragon Institute of MGH, MIT and Harvard), Tomer Zohar(Ragon Institute of MGH, MIT and Harvard), Caitlin R. Wolf(University of Washington), Matthew D. Slein(The University of Texas at Austin), Kiel Shuey(University of Washington), Helen Y. Chu(Seattle Pacific University), Todd J. Suscovich, Yongfei Cai(Boston Children's Hospital)
Cited by 420
Related Papers
Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19
|New England Journal of Medicine|2021|2.6k
Persistence and Evolution of SARS-CoV-2 in an Immunocompromised Host
|New England Journal of Medicine|2020|1.4k
DNA vaccine protection against SARS-CoV-2 in rhesus macaques
|Science|2020|1.1k
SARS-CoV-2 viral load is associated with increased disease severity and mortality
|Nature Communications|2020|981